According to GlaxoSmithKline's latest financial reports the company's current EPS (TTM) is 3,08ย โฌ. In 2022 the company made an earnings per share (EPS) of 7,46ย โฌ an increase over its 2021 EPS that were of 2,63ย โฌ.